Since the fetus is an allogeneic graft in the uterus of the mother, at least in all pregnancies resulting from heterospecific matings, nature must have provided some particular protective mechanism to prevent its rejection. To explain the peculiar immunological fetal-maternal relationship, different theories have been proposed, none of which is entirely supported by the experimental data (Beer and Billingham, 1971). Whatever the protective mechanisminvolved, we thought it worthwhile to explore the possibility that this special immunological relationship between fetus and mother may be used in experimental oncology. It is a well established finding that many oncogenie viruses only give rise to tumors when injected in immunologically poorly competent animals, e.g. newborns or immunosuppressed rodents. The resistance of adult competent animals to the oncogenie activity of viruses is based upon the development in these animals of an efficient cellular immunity directed against the tumor-associated transplantation antigens (TATA). This cellular immunity leads then to the rejection of the neoplastic cell clones. Since during pregnancy the fetal environment is protected against immune aggression of maternal sensitized lymphocytes, the pregnant uterus may be a privileged site for the induction of tumors of viral origin and displaying strong TATA.
Read full abstract